Literature DB >> 7880243

Normal transcutaneous oxygen pressure in skin after radiation therapy for cancer.

R Rudolph1, P Tripuraneni, J A Koziol, M McKean-Matthews, A Frutos.   

Abstract

BACKGROUND: Chronic deleterious changes in human skin after radiation therapy often have been ascribed to progressive ischemia (decreased blood supply and oxygenation). Recent studies suggest, however, that damaged irradiated skin is not ischemic. Transcutaneous oxygen pressure (TCPO2), that accurately reflects skin oxygenation, was studied in 100 patients who had undergone prior extensive radiation therapy for cancer.
METHODS: In the 100 patients, the mean time since radiation was 7.86 +/- 10.56 years (mean, +/- SD) (range, 1-58 years). Radiation skin effects were graded (0-4+), and TCPO2 was measured in irradiated and control nonirradiated sites, with patients first breathing room air, then 100% O2 6 l/min for 10 minutes. Data were stratified according to skin grades, sex, time since irradiation, site, type, and dose of radiation.
RESULTS: The mean TCPO2 in patients breathing room air was 52.0 17.8 mm Hg (mean +/- SD) for all irradiated skin, compared with 131.8 +/- 51.1 at the same irradiated sites in response to oxygen breathing (P < 0.0001); the mean TCPO2 for normal, nonirradiated skin was 56.5 +/- 12.6 when patients were breathing room air, compared with 151.5 +/- 48.1 when breathing 100% oxygen (P < 0.0001). Higher skin damage grades correlated with increasing time after radiation therapy. However, neither increasing time after irradiation nor grade of skin damage correlated with TCPO2, which was normal in 88% of the patients.
CONCLUSIONS: Human skin, even many decades after radiation therapy, retains normal tissue oxygenation and TCPO2 response to inspired oxygen. Postradiation scarring, poor healing, and rare ulceration are not solely due to ischemia and may be caused by other radiation effects, such as permanent changes in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7880243     DOI: 10.1002/1097-0142(19941201)74:11<3063::aid-cncr2820741126>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Radiotherapy and wound healing.

Authors:  Emma-Louise Dormand; Paul E Banwell; Timothy E E Goodacre
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

Review 2.  Radiotherapy and wound healing.

Authors:  Haresh L Devalia; Lucy Mansfield
Journal:  Int Wound J       Date:  2007-12-12       Impact factor: 3.315

3.  The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer.

Authors:  Sang-wook Lee; Sue Young Moon; Yeun Hwa Kim; Joon Pio Hong
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

Review 4.  Adipose-derived stem cells in radiotherapy injury: a new frontier.

Authors:  Lipi Shukla; Wayne A Morrison; Ramin Shayan
Journal:  Front Surg       Date:  2015-01-28

5.  Topical Fibronectin Improves Wound Healing of Irradiated Skin.

Authors:  Maxwell B Johnson; Brandon Pang; Daniel J Gardner; Solmaz Niknam-Benia; Vinaya Soundarajan; Athanasios Bramos; David P Perrault; Kian Banks; Gene K Lee; Regina Y Baker; Gene H Kim; Sunju Lee; Yang Chai; Mei Chen; Wei Li; Lawrence Kwong; Young-Kwon Hong; Alex K Wong
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

6.  Mesenchymal Stromal Cells Isolated from Irradiated Human Skin Have Diminished Capacity for Proliferation, Differentiation, Colony Formation, and Paracrine Stimulation.

Authors:  Maxwell B Johnson; Solmaz Niknam-Bienia; Vinaya Soundararajan; Brandon Pang; Eunson Jung; Daniel J Gardner; Xingtian Xu; Sun Y Park; Charles Wang; Xin Chen; Regina Y Baker; Mei Chen; Young-Kwon Hong; Wei Li; Alex K Wong
Journal:  Stem Cells Transl Med       Date:  2019-04-24       Impact factor: 6.940

7.  Myofibroblasts and their resistance to apoptosis: a possible mechanism of osteoradionecrosis.

Authors:  Lei Tian; Li-Sheng He; Bhavesh Soni; Hong-Tao Shang
Journal:  Clin Cosmet Investig Dent       Date:  2012-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.